Arctic Therapeutics
Business Services · Iceland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gróska Innovation Center 1 Bjargargata, ...Website
www.arctictherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Arctic Therapeutics
Arctic Therapeutics identifies the genetic causes of major diseases, accelerating the development of effective treatments for millions of patients. They apply bioinformatic approaches and AI to reduce risks and costs in drug development, collaborating with institutions like the Childrens Hospital of Philadelphia. With a focus on genetic sequencing and unique drug development approaches, they are advancing treatments for conditions like Alzheimers, autoimmune diseases, and severe asthma.Explore more
Arctic Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arctic Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Arctic Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Arctic Therapeutics
Click to see if Arctic Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Arctic Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check out if Arctic Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Arctic Therapeutics has new funding data
Arctic Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Arctic Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Arctic Therapeutics
Compare insights from companies similar to Arctic Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arctic Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Arctic Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Arctic Therapeutics.
Arctic Therapeutics financials insights
Gather financial insights about Arctic Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$27.4M
Arctic Therapeutics Tech Stack
A closer look at the technologies used by Arctic Therapeutics
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Funding
Arctic Therapeutics News & Media
Arctic Therapeutics Announces Enrollment of First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris
Acne vulgaris affects an estimated 650 million people worldwide with a significant impact on quality of life, mental well-being, and self-esteem. AT-004 targets a novel, TNF-α-modulating anti-inflammatory pathway in the skin, with relevance across multiple inflammatory dermatologic...Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer's Disease
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer's disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK,...Arctic Therapeutics research suggests preventative strategy against HCCAA
N-acetylcysteine (NAC) shows promise to treat hereditary cystatin C amyloid angiopathy (HCCAA) HCCAA – a subtype of cerebral amyloid angiopathy (CAA) – is an ultra-rare Icelandic amyloid disease due to a mutation in the CST3 gene encoding for the protease inhibitor, cystatin C. HCCAA...Arctic Therapeutics: Drug Discovery Company Raises €26.5 Million (Series A)
Icelandic drug discovery and development company Arctic Therapeutics (ATx) announced the closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of international investors. This syndicate includes the EIC Fund, Iceland's largest privately-held investment firm Kaldbakur, Investcorp-backed Sanos Group, Swiss-based Cerebrum DAO, The Lurie Family Foundation – established by US billionaire Jeffery Lurie, and a consortium led by early investors and co-founders of Icelandic
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arctic Therapeutics
Sign Up For FreeTo access detailed company insights
Arctic Therapeutics identifies the genetic causes of major diseases, accelerating the development of effective treatments for millions of patients. They apply bioinformatic approaches and AI to reduce risks and costs in drug development, collaborating with institutions like the Childrens Hospital of Philadelphia. With a focus on genetic sequencing... Read More
